Cargando…

Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities

Background: Naltrexone, a medication for addiction treatment (MAT), is an FDA-approved medication recommended for the treatment of alcohol use disorder (AUD). Despite the high prevalence of AUD and efficacy of naltrexone, only a small percentage of individuals with AUD receive treatment. Objectives:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qeadan, Fares, Mensah, Nana A., Gu, Lily Y., Madden, Erin F., Venner, Kamilla L., English, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394149/ https://www.ncbi.nlm.nih.gov/pubmed/34444639 http://dx.doi.org/10.3390/ijerph18168884

Ejemplares similares

Psychostimulant Misuse Among American Indian, Alaskan Native, or Native Hawaiian College Students in the U.S. From 2015 to 2019
por: Qeadan, Fares, et al.
Publicado: (2023)

Epidemiological trends in opioid-only and opioid/polysubstance-related death rates among American Indian/Alaska Native populations from 1999 to 2019: a retrospective longitudinal ecological study
por: Qeadan, Fares, et al.
Publicado: (2022)

A trend analysis of the prevalence of opioid misuse, social support, and suicide attempt among American Indian/Alaska native high school students in New Mexico: 2009–2019 Youth Risk Resiliency Survey (YRRS)
por: Agyemang, Daniel Opoku, et al.
Publicado: (2022)

The mediation and moderation effect of social support on the relationship between opioid misuse and suicide attempts among native American youth in New Mexico: 2009-2019 Youth Risk Resiliency Survey (NM-YRRS)
por: Agyemang, Daniel Opoku, et al.
Publicado: (2022)

Correction: The mediation and moderation effect of social support on the relationship between opioid misuse and suicide attempts among native American youth in New Mexico: 2009-2019 Youth Risk Resiliency Survey (NM-YRRS)
por: Agyemang, Daniel Opoku, et al.
Publicado: (2022)

Unemployment rate, opioids misuse and other substance abuse: quasi-experimental evidence from treatment admissions data
por: Azagba, Sunday, et al.
Publicado: (2021)

The frequency of agitation due to inappropriate use of naltrexone in addicts
por: Siadat, Sima, et al.
Publicado: (2014)

Utilization of addiction treatment among U.S. adults with history of incarceration and substance use disorders
por: Tsai, Jack, et al.
Publicado: (2019)

Monitoring and Improving Naltrexone Adherence in Patients with Substance Use Disorder
por: Perez-Macia, Virginia, et al.
Publicado: (2021)

Adverse drug reactions with naltrexone: Experience from an addiction treatment center
por: Sarkar, Siddharth, et al.
Publicado: (2021)

Treatment of psoriasis vulgaris using low-dose naltrexone
por: Bridgman, Alanna C., et al.
Publicado: (2018)

Treatment outcomes of long-acting injectable naltrexone versus oral naltrexone in alcohol use disorder in veterans
por: Leighty, Anne E., et al.
Publicado: (2019)

The association between opioids, environmental, demographic, and socioeconomic indicators and COVID-19 mortality rates in the United States: an ecological study at the county level
por: Qeadan, Fares, et al.
Publicado: (2021)

Pilot outcome results of culturally adapted evidence-based substance use disorder treatment with a Southwest Tribe
por: Venner, Kamilla L., et al.
Publicado: (2015)

Adoption of telemedicine services by substance abuse treatment facilities in the U.S.
por: Uscher-Pines, Lori, et al.
Publicado: (2020)

Naltrexone and the Treatment of Alcohol Dependence
por: Volpicelli, Joseph R., et al.
Publicado: (1994)

A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use
por: Wiercigroch, David, et al.
Publicado: (2020)

A descriptive survey of substance use treatment facilities in Uasin Gishu County Kenya
por: Jaguga, Florence, et al.
Publicado: (2022)

Views about responsibility for alcohol addiction and negative evaluations of naltrexone
por: Johnson, Rebecca A, et al.
Publicado: (2015)

Changes in Admissions to Specialty Addiction Treatment Facilities in California During the COVID-19 Pandemic
por: Mark, Tami L., et al.
Publicado: (2021)

Naltrexone Implant for Opioid Use Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

Use of Naltrexone in Internet Gaming Disorder
por: Gour, Rahul, et al.
Publicado: (2022)

The association between dual use of electronic nicotine products and illicit drugs with adverse cardiovascular and respiratory outcomes in a longitudinal analysis using the Population Assessment of Tobacco and Health (PATH) survey
por: Qeadan, Fares, et al.
Publicado: (2023)

Opioid use disorder and health service utilization among COVID-19 patients in the US: A nationwide cohort from the Cerner Real-World Data
por: Qeadan, Fares, et al.
Publicado: (2021)

Mental distress following inpatient substance use treatment, modified by substance use; comparing voluntary and compulsory admissions
por: Pasareanu, Adrian R., et al.
Publicado: (2017)

The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis
por: Qeadan, Fares, et al.
Publicado: (2021)

Substance use and addiction research in India
por: Murthy, Pratima, et al.
Publicado: (2010)

Use of methyl-naltrexone for the treatment of opioid-induced constipation in critical care patients
por: Sawh, SB, et al.
Publicado: (2010)

Adding Psychotherapy to the Naltrexone Treatment of Alcohol Use Disorder: Meta-analytic Review
por: Ahmed, Rizwan, et al.
Publicado: (2018)

Effectiveness of naltrexone treatment for alcohol use disorders in HIV: a systematic review
por: Farhadian, Negin, et al.
Publicado: (2020)

Barriers to addiction treatment among formerly incarcerated adults with substance use disorders
por: Owens, Mandy D., et al.
Publicado: (2018)

Improved Quality of Life Following Addiction Treatment Is Associated with Reductions in Substance Use
por: Manning, Victoria, et al.
Publicado: (2019)

The Role of Food Addiction and Lifetime Substance Use on Eating Disorder Treatment Outcomes
por: Miranda-Olivos, Romina, et al.
Publicado: (2023)

Multidisciplinary and Integrated Treatment for Substance Use Disorders and Hepatitis C in an Addiction Treatment Service in India
por: Ghosh, Abhishek, et al.
Publicado: (2022)

Levels of Impulsivity, Hyperactivity, and Inattention and the Association with Mental Health and Substance Use Severity in Opioid-Dependent Patients Seeking Treatment with Extended-Release Naltrexone
por: Karlsson, Ann Tarja, et al.
Publicado: (2021)

Exploring racial/ethnic differences in substance use: a preliminary theory-based investigation with juvenile justice-involved youth
por: Feldstein Ewing, Sarah W, et al.
Publicado: (2011)

Co-occurring mental disorders in treatment admissions for substance use disorders in Maryland
por: Moyo, Patience, et al.
Publicado: (2015)

Treatment of Complex Regional Pain Syndrome (CRPS) Using Low Dose Naltrexone (LDN)
por: Chopra, Pradeep, et al.
Publicado: (2013)

An exploratory study of cannabis use pattern and treatment seeking in patients attending an addiction treatment facility
por: Sarkar, Siddharth, et al.
Publicado: (2020)

Associations between naloxone prescribing and opioid overdose among patients with acute and chronic pain conditions
por: Qeadan, Fares, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ombr0imsai0kh78olvc3egso52